Display options
Cite
Hebbar M, Chibaudel B, André T, et al. FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. Ann Oncol. 2015;26(5):1040doi: 10.1093/annonc/mdv141.
Hebbar, M., Chibaudel, B., André, T., Mineur, L., Smith, D., Louvet, C., Dutel, J. L., Ychou, M., Legoux, J. L., Mabro, M., Faroux, R., Auby, D., Brusquant, D., Khalil, A., Truant, S., Hadengue, A., Dalban, C., Gayet, B., Paye, F., Pruvot, F. R., Bonnetain, F., de Gramont, A. (2015). FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology, 26(5), 1040. https://doi.org/10.1093/annonc/mdv141
Hebbar, M, et al. "FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial." Annals of oncology : official journal of the European Society for Medical Oncology vol. 26,5 (2015): 1040. doi: https://doi.org/10.1093/annonc/mdv141
Hebbar M, Chibaudel B, André T, Mineur L, Smith D, Louvet C, Dutel JL, Ychou M, Legoux JL, Mabro M, Faroux R, Auby D, Brusquant D, Khalil A, Truant S, Hadengue A, Dalban C, Gayet B, Paye F, Pruvot FR, Bonnetain F, de Gramont A. FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial. Ann Oncol. 2015 May;26(5):1040. doi: 10.1093/annonc/mdv141. PMID: 25900678.
Copy Download .nbib Format: NLM
Share it on

Ann Oncol. 2015 May;26(5):1040. doi: 10.1093/annonc/mdv141.

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology

M Hebbar, B Chibaudel, T André, L Mineur, D Smith, C Louvet, J L Dutel, M Ychou, J L Legoux, M Mabro, R Faroux, D Auby, D Brusquant, A Khalil, S Truant, A Hadengue, C Dalban, B Gayet, F Paye, F R Pruvot, F Bonnetain, A de Gramont,

Affiliations

  1. Department of Medical Oncology, University Hospital, Lille.
  2. Department of Medical Oncology, Hospital Saint-Antoine, Paris.
  3. Department of Radiotherapy, Institute Sainte-Catherine, Avignon.
  4. Department of Medical Oncology and Radiotherapy, Hospital Saint-André, Bordeaux.
  5. Department of Oncology, Institute Mutualiste Montsouris, Paris.
  6. Department of Medical Oncology, Radiotherapy Service, Hospital Centre Beauvais, Beauvais.
  7. Regional Centre against Cancer, Val d'Aurelle-Paul Lamarque, Montpellier.
  8. Department of Hepatology and Gastroenterology, Hospital de Haut-Lévêque, Pessac.
  9. Department of Medical Oncology, Hospital Foch, Suresnes.
  10. Department of Gastroenterology, Hospital La Roche-sur-Yon, La Roche-sur-Yon.
  11. Department of Medicine, Hospital Libourne, Libourne.
  12. GERCOR, Paris.
  13. Department of Medical Oncology, Hospital Tenon, Paris.
  14. Department of Digestive Surgery and Transplantation, University Hospital, Lille.
  15. Methodology and Quality of Life in Oncology Department EA 3181, Hospital Besançon, Besançon.
  16. Department of Surgery, Institute Mutualiste Montsouris, Paris.
  17. Department of Digestive Surgery, Hospital Saint-Antoine, Paris, France.

PMID: 25900678 DOI: 10.1093/annonc/mdv141

[No abstract available.]

Publication Types